Effect of direct-acting antiviral (DAA) drugs on HCV epidemiology among patients in public hospitals in southern Hessen, Germany.
- Conditions
- Patients' blood is tested for hepatitis C virus (HCV) antibodies. If the result is positive, the next step is to check for HCV RNA to detect an active infection.
- Registration Number
- DRKS00028846
- Lead Sponsor
- Johann Wolfgang Goethe-Universität Frankfurt
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 10000
Inclusion Criteria
Consenting patients over the age of 18 presenting for elective surgery or emergency care to a public hospital in southern Hessen, Germany
Exclusion Criteria
Patients under 18 years of age, patients with a known HCV infection
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Prevalence of hepatitis C antibodies in patients presenting for elective surgery or emergency care i to a public hospital in southern Hessen, Germany. <br>
- Secondary Outcome Measures
Name Time Method Effect of therapy (direct-acting antiviral drugs) on the prevalence of infection with HCV.